help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tremblay, A.
Right arrow Articles by Giguère, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tremblay, A.
Right arrow Articles by Giguère, V.
Endocrinology Vol. 139, No. 1 111-118
Copyright © 1998 by The Endocrine Society

ARTICLES

EM-800, a Novel Antiestrogen, Acts as a Pure Antagonist of the Transcriptional Functions of Estrogen Receptors {alpha} and ß1

André Tremblay2, Gilles B. Tremblay2, Claude Labrie, Fernand Labrie and Vincent Giguère

Molecular Oncology Group, Royal Victoria Hospital (A.T., G.B.T., V.G.), the Departments of Biochemistry, Medicine, and Oncology, McGill University (V.G.), Montreal, Québec, Canada H3A 1A1; and the Laboratory of Molecular Endocrinology, CHUL Research Center (C.L., F.L.), Québec City, Québec, Canada G1V 4G2

Address all correspondence and requests for reprints to: Dr. Vincent Giguère, Molecular Oncology Group, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Québec, Canada H3A 1A1. E-mail: vgiguere{at}dir.molonc.mcgill.ca

Estrogens act as potent mitogens in a large number of breast cancers, and the use of estrogen receptor (ER) antagonists is, therefore, considered the endocrine therapy of choice in the management of this disease. We describe the molecular properties of EM-652, the active metabolite of EM-800, a novel nonsteroidal antiestrogen compound, on the transcriptional functions of ER{alpha} and ERß. Using RT-PCR, we show that ER{alpha} and ERß are expressed in mouse mammary glands, suggesting that both receptors should be considered putative targets for antiestrogen action in the breast. In cotransfection assays using a synthetic estrogen-responsive promoter, EM-652 shows no agonistic activity on ER{alpha} and ERß transcriptional function and blocks the estradiol (E2)-mediated activation of both ER{alpha} and ERß. EM-652 is also very effective in abrogating E2-stimulated ER{alpha} and ERß trans-activation of the pS2 promoter in HeLa cells. EM-652 does not alter binding of ER{alpha} and ERß to DNA. The Ras-mediated induction of ER{alpha} and ERß transcriptional activity in the presence of E2 is also completely abolished by EM-652. In addition, EM-652 blocks the E2-dependent activation of ER{alpha} and ERß by the steroid hormone receptor coactivator-1 as well as the in vitro interaction between SRC-1 and the ligand-binding domains of both ERs. These results demonstrate that the novel antiestrogen EM-800 fully impedes AF-1 and AF-2 activities of ER{alpha} and ERß and can, therefore, be considered a potent and pure antagonist of both ER subtypes.




This article has been cited by other articles:


Home page
 Toxicol PatholHome page
D. G. Rudmann, I. R. Cohen, M. R. Robbins, D. E. Coutant, and J. W. Henck
Androgen Dependent Mammary Gland Virilism in Rats Given the Selective Estrogen Receptor Modulator LY2066948 Hydrochloride
Toxicol Pathol, October 1, 2005; 33(6): 711 - 719.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. Lemieux, Y. Gelinas, J. Lalonde, F. Labrie, K. Cianflone, and Y. Deshaies
Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors
J. Lipid Res., June 1, 2005; 46(6): 1285 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. J. Fabian and B. F. Kimler
Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer
J. Clin. Oncol., March 10, 2005; 23(8): 1644 - 1655.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. R. Schultz, L. N. Petz, and A. M. Nardulli
Cell- and Ligand-specific Regulation of Promoters Containing Activator Protein-1 and Sp1 Sites by Estrogen Receptors {alpha} and {beta}
J. Biol. Chem., January 7, 2005; 280(1): 347 - 354.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. Labrie, P. Champagne, C. Labrie, J. Roy, J. Laverdiere, L. Provencher, M. Potvin, Y. Drolet, M. Pollak, L. Panasci, et al.
Activity and Safety of the Antiestrogen EM-800, the Orally Active Precursor of Acolbifene, in Tamoxifen-Resistant Breast Cancer
J. Clin. Oncol., March 1, 2004; 22(5): 864 - 871.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Labrie, M. El-Alfy, L. Berger, C. Labrie, C. Martel, A. Belanger, B. Candas, and G. Pelletier
The Combination of a Novel Selective Estrogen Receptor Modulator with an Estrogen Protects the Mammary Gland and Uterus in a Rodent Model: The Future of Postmenopausal Women's Health?
Endocrinology, November 1, 2003; 144(11): 4700 - 4706.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
K. D. Carpenter, C. A. Gray, T. M. Bryan, T. H. Welsh Jr., and T. E. Spencer
Estrogen and Antiestrogen Effects on Neonatal Ovine Uterine Development
Biol Reprod, August 1, 2003; 69(2): 708 - 717.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
C. A. Oliveira, K. Carnes, L. R. Franca, and R. A. Hess
Infertility and Testicular Atrophy in the Antiestrogen-Treated Adult Male Rat
Biol Reprod, September 1, 2001; 65(3): 913 - 920.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Lu and V. Giguere
Requirement of Ras-Dependent Pathways for Activation of the Transforming Growth Factor {beta}3 Promoter by Estradiol
Endocrinology, February 1, 2001; 142(2): 751 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
F. Sauvé, L. D. B. McBroom, J. Gallant, A. N. Moraitis, F. Labrie, and V. Giguère
CIA, a Novel Estrogen Receptor Coactivator with a Bifunctional Nuclear Receptor Interacting Determinant
Mol. Cell. Biol., January 1, 2001; 21(1): 343 - 353.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
W. P. Bocchinfuso, J. K. Lindzey, S. C. Hewitt, J. A. Clark, P. H. Myers, R. Cooper, and K. S. Korach
Induction of Mammary Gland Development in Estrogen Receptor-{alpha} Knockout Mice
Endocrinology, August 1, 2000; 141(8): 2982 - 2994.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. K. Dubey, E. K. Jackson, D. G. Gillespie, L. C. Zacharia, B. Imthurn, and P. J. Keller
Clinically Used Estrogens Differentially Inhibit Human Aortic Smooth Muscle Cell Growth and Mitogen-Activated Protein Kinase Activity
Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 964 - 972.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Saville, M. Wormke, F. Wang, T. Nguyen, E. Enmark, G. Kuiper, J.-A. Gustafsson, and S. Safe
Ligand-, Cell-, and Estrogen Receptor Subtype (alpha /beta )-dependent Activation at GC-rich (Sp1) Promoter Elements
J. Biol. Chem., February 25, 2000; 275(8): 5379 - 5387.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Schapira, B. M. Raaka, H. H. Samuels, and R. Abagyan
Rational discovery of novel nuclear hormone receptor antagonists
PNAS, February 1, 2000; 97(3): 1008 - 1013.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
G. Pelletier, V. Luu-The, A. Charbonneau, and F. Labrie
Cellular Localization of Estrogen Receptor Beta Messenger Ribonucleic Acid in Cynomolgus Monkey Reproductive Organs
Biol Reprod, November 1, 1999; 61(5): 1249 - 1255.
[Abstract] [Full Text]

Home page
 J. Histochem. Cytochem.Home page
N. Zeps, J. M. Bentel, J. M. Papadimitriou, and H. J.S. Dawkins
Murine Progesterone Receptor Expression in Proliferating Mammary Epithelial Cells During Normal Pubertal Development and Adult Estrous Cycle: Association with ER{alpha} and ER{beta} Status
J. Histochem. Cytochem., October 1, 1999; 47(10): 1323 - 1330.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. Couillard, M. Gutman, F. Labrie, B. Candas, and C. Labrie
Effect of Combined Treatment with the Pure Antiestrogen EM-800 and Radiotherapy on the Growth of Human ZR-75-1 Breast Cancer Xenografts in Nude Mice
Cancer Res., October 1, 1999; 59(19): 4857 - 4863.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Gutman, S. Couillard, F. Labrie, B. Candas, and C. Labrie
Effects of the Antiestrogen EM-800 (SCH 57050) and Cyclophosphamide Alone and in Combination on Growth of Human ZR-75-1 Breast Cancer Xenografts in Nude Mice
Cancer Res., October 1, 1999; 59(20): 5176 - 5180.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. P. Bocchinfuso, W. P. Hively, J. F. Couse, H. E. Varmus, and K. S. Korach
A Mouse Mammary Tumor Virus-Wnt-1 Transgene Induces Mammary Gland Hyperplasia and Tumorigenesis in Mice Lacking Estrogen Receptor-{{alpha}}
Cancer Res., April 1, 1999; 59(8): 1869 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
G. B. Tremblay, A. Tremblay, F. Labrie, and V. Giguere
Dominant Activity of Activation Function 1 (AF-1) and Differential Stoichiometric Requirements for AF-1 and -2 in the Estrogen Receptor alpha -beta Heterodimeric Complex
Mol. Cell. Biol., March 1, 1999; 19(3): 1919 - 1927.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. Chen, P. E. Pace, R. C. Coombes, and S. Ali
Phosphorylation of Human Estrogen Receptor alpha  by Protein Kinase A Regulates Dimerization
Mol. Cell. Biol., February 1, 1999; 19(2): 1002 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. A. Shupnik, L. K. Pitt, A. Y. Soh, A. Anderson, M. B. Lopes, and E. R. Laws Jr.
Selective Expression of Estrogen Receptor {alpha} and {beta} Isoforms in Human Pituitary Tumors
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3965 - 3972.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Ördög, J. R. Goldsmith, M.-D. Chen, M. A. Connaughton, J. Hotchkiss, and E. Knobil
On the Mechanism of the Positive Feedback Action of Estradiol on Luteinizing Hormone Secretion in the Rhesus Monkey
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4047 - 4053.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society